Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of ₹1,546 Crore up from ₹1,430.47 Crore year on year, a growth of 8%. The Consolidated Net Profit of ₹107.84 Crore, down 45% from ₹196.96 Crore in the same quarter of the previous year. The Earnings per Share is ₹4.25 for this quarter.
Ipca Laboratories Limited Q3 FY23; Revenue Increased To ₹1,546 Crore
Tags: pharmaceuticals
Related Post
- Titagarh Rail Systems Ltd Q4 FY24 Earnings Conference Call Insights
Key highlights from Titagarh Rail Systems Ltd (TITAGARH) Q4 FY24 Earnings Concall Operations Highlights The…
-
Zee Entertainment Enterprises Ltd Q4FY24; 3% rise in Revenue
Zee Entertainment Enterprises is mainly in the following businesses: Broadcasting of Satellite Television Channels, Space…
-
Zydus Lifesciences Ltd Q4FY24; 248% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis…